Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F1L61
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,970
Award facts
- Contract value 100% obligated
- $39,970.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $39,970.48 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens on December 2, 2025, with completion expected by December 3, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant medication used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, supporting the military healthcare system's pharmaceutical supply chain.
This delivery order represents a routine transaction within AmerisourceBergen's broader role as a prime pharmaceutical vendor for federal military medical procurement. As a major pharmaceutical distributor, AmerisourceBergen maintains extensive contracts with DLA to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. The company's large IDC framework enables flexible, rapid procurement of critical pharmaceutical products needed to support military readiness and veteran care worldwide.
Quick answers
Who was awarded contract SPE2DR26F1L61?
SPE2DR26F1L61 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F1L61 worth?
The government has obligated $39,970 on SPE2DR26F1L61.
Is contract SPE2DR26F1L61 an order under another contract?
Yes. SPE2DR26F1L61 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1L61 competed?
The extent of competition for SPE2DR26F1L61 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award